First detection of the melanoma-predisposing proline-48-threonine mutation of p16 in Hungarians: was there a common founder either in Italy or in Hungary?

The P48T germ line mutation of p16 was detected in a Hungarian multiple primary melanoma patient (deceased at the age of 39) with no affected family members. Genetic analysis of the patient and his family revealed that the patient was homozygous for the mutation, whereas his parents (father currently aged 69 and mother 63), who are free from any malignancies and atypical moles, are both heterozygous for the mutation. Our data suggest that the P48T mutation of p16 is a strong melanoma-predisposing factor, but the fact that the heterozygous mutant parents have not yet exhibited melanoma or atypical moles indicates that the penetrance of this allele might depend on modifying factors. The rare P48T germ line mutation of p16 has been reported previously in only four independent studies, all in patients with Italian ancestry. Here, we first report the inheritance of the rare P48T mutation of CDKN2A in a Hungarian family with a homozygous multiple primary melanoma member and unaffected heterozygous family members. The question of whether the mutation detected in Hungary is the result of an independent event, or migration of the founder mutation occurred at some time in the past, necessitates further investigations.

[1]  L. Cannon-Albright,et al.  Population-based prevalence of CDKN2A mutations in Utah melanoma families. , 2006, The Journal of investigative dermatology.

[2]  J. Huber,et al.  The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[3]  M. Sormani,et al.  Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients , 2004, Melanoma research.

[4]  W. Placek,et al.  FAMMM Syndrome: Pathogenesis and Management , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[5]  H. Cavé,et al.  Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma , 2004, British Journal of Cancer.

[6]  L. Chin,et al.  The INK4a/ARF locus and melanoma , 2003, Oncogene.

[7]  N. Hayward.  Genetics of melanoma predisposition , 2003, Oncogene.

[8]  Florence Demenais,et al.  Geographical variation in the penetrance of CDKN2A mutations for melanoma. , 2002, Journal of the National Cancer Institute.

[9]  G. Peters,et al.  CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation , 2001, British Journal of Cancer.

[10]  A. Scarpa,et al.  A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma , 2000, Human mutation.

[11]  H. Höfler,et al.  CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds. , 1998, The Journal of investigative dermatology.

[12]  G. Peters,et al.  The p16INK4a/CDKN2A tumor suppressor and its relatives. , 1998, Biochimica et biophysica acta.

[13]  Manuel Serrano,et al.  Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d , 1998, Nature.

[14]  M. Inganäs,et al.  Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. , 1997, Journal of the National Cancer Institute.

[15]  N. Martin,et al.  The Queensland Familial Melanoma Project: study design and characteristics of participants , 1996, Melanoma research.

[16]  L. Sandkuijl,et al.  Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.

[17]  M. Skolnick,et al.  Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. , 1992, Science.

[18]  N. Puizina-Ivic,et al.  Alterations in CDKN2A locus as potential indicator of melanoma predisposition in relatives of non-familial melanoma cases. , 2003, Croatian medical journal.

[19]  Kerstin,et al.  High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. , 2000, Journal of the National Cancer Institute.